DE3337207C2 - - Google Patents

Info

Publication number
DE3337207C2
DE3337207C2 DE3337207A DE3337207A DE3337207C2 DE 3337207 C2 DE3337207 C2 DE 3337207C2 DE 3337207 A DE3337207 A DE 3337207A DE 3337207 A DE3337207 A DE 3337207A DE 3337207 C2 DE3337207 C2 DE 3337207C2
Authority
DE
Germany
Prior art keywords
alkyl
hydrogen
general formula
methyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3337207A
Other languages
German (de)
English (en)
Other versions
DE3337207A1 (de
Inventor
Francarosa Baccichetti
Franco Padova It Bordin
Carlo Trieste It Bragadin Monti
Francesco Padova It Carlassare
Mario Trento It Cristofolini
Francesco Dall'acqua
Adriano Guiotto
Giovanni Padova It Pastorini
Giovanni Trento It Recchia
Giovanni Rodighiero
Paolo Rodighiero
Daniela Padova It Vedaldi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consiglio Nazionale delle Richerche
Original Assignee
Consiglio Nazionale delle Richerche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consiglio Nazionale delle Richerche filed Critical Consiglio Nazionale delle Richerche
Publication of DE3337207A1 publication Critical patent/DE3337207A1/de
Application granted granted Critical
Publication of DE3337207C2 publication Critical patent/DE3337207C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19833337207 1982-10-18 1983-10-13 Verfahren zur herstellung von psoralenfreien alkylangelicinen Granted DE3337207A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT84148/82A IT1165797B (it) 1982-10-18 1982-10-18 Procedimento di preparazione di alchilangelicine esenti da psoraleni ed alchilangolicine ottenute col procedimento

Publications (2)

Publication Number Publication Date
DE3337207A1 DE3337207A1 (de) 1984-04-19
DE3337207C2 true DE3337207C2 (enExample) 1991-12-19

Family

ID=11324788

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19833337207 Granted DE3337207A1 (de) 1982-10-18 1983-10-13 Verfahren zur herstellung von psoralenfreien alkylangelicinen

Country Status (12)

Country Link
US (1) US5001147A (enExample)
JP (1) JPH0633269B2 (enExample)
AT (1) AT384810B (enExample)
AU (1) AU559082B2 (enExample)
CA (1) CA1228860A (enExample)
CH (1) CH662566A5 (enExample)
DE (1) DE3337207A1 (enExample)
ES (1) ES8608523A1 (enExample)
FR (1) FR2534585B1 (enExample)
GB (1) GB2128997B (enExample)
IT (1) IT1165797B (enExample)
ZA (1) ZA837585B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1242055T3 (da) * 1999-12-23 2008-07-21 Pfizer Prod Inc Hydrogelstyret doseringsform til lægemidler
NZ594784A (en) * 2005-08-18 2013-06-28 Genmab As Therapy with CD4 binding peptides and radiation
ITVE20070005A1 (it) 2007-01-25 2008-07-26 Associazione Veneta Per La Lotta Alla Talassemia Farmaco per la cura della talassemia, dell'anemia falciforme e di tutte le altre forme di anemia trattabili con questo, metodo di attivazione del farmaco, composizione farmaceutica avente come principio attivo il farmaco e metodo fotochemioterapico u
US8420836B2 (en) 2008-10-21 2013-04-16 Kao Corporation NFAT signal inhibitor and hair-growing agent
CN105832720B (zh) * 2016-05-03 2019-04-05 中国科学院新疆理化技术研究所 一种补骨脂素类化合物的用途
CN116554191B (zh) * 2023-05-06 2025-12-05 河南中烟工业有限责任公司 一种香柑内酯的合成方法
CN116554190B (zh) * 2023-05-06 2025-12-05 河南中烟工业有限责任公司 一种香柑醇的合成方法及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI59598C (fi) * 1977-10-03 1981-09-10 Star Oy Ab Nytt foerfarande foer framstaellning av i 9-staellningen eventuellt metoxisubstituerade 7h-furo(3,2-g)(1)bensopyran-7-oner
JPS55124775A (en) * 1979-03-13 1980-09-26 Elder Thomas C Inc Alphaalower alkylfurocoumarin manufacture and intermediate oftained therefrom
US4216154A (en) * 1979-03-15 1980-08-05 Thomas C. Elder, Inc. Process for making α-loweralkylfurocoumarins
IT1166343B (it) * 1979-08-20 1987-04-29 Francarosa Baccichetti Furocumarina per la fotochemioterapia della fsoriasi e di altre malattie cutanee ad essa sensibili

Also Published As

Publication number Publication date
AU2014183A (en) 1984-05-03
ES526910A0 (es) 1986-07-16
CH662566A5 (it) 1987-10-15
IT1165797B (it) 1987-04-29
GB2128997A (en) 1984-05-10
AT384810B (de) 1988-01-11
ATA370383A (de) 1987-06-15
ES8608523A1 (es) 1986-07-16
US5001147A (en) 1991-03-19
FR2534585A1 (fr) 1984-04-20
DE3337207A1 (de) 1984-04-19
JPH0633269B2 (ja) 1994-05-02
AU559082B2 (en) 1987-02-19
GB8327200D0 (en) 1983-11-09
IT8284148A0 (it) 1982-10-18
ZA837585B (en) 1984-06-27
CA1228860A (en) 1987-11-03
JPS59104387A (ja) 1984-06-16
GB2128997B (en) 1985-12-24
FR2534585B1 (fr) 1986-12-19

Similar Documents

Publication Publication Date Title
DE3031164C2 (de) Angelicine enthaltende Arzneimittel, Angelicine als solche sowie Verfahren zu deren Herstellung
DE2858042C2 (de) Rechtsdrehendes Isomer eines asymmetrischen Spirohydantoins sowie der Basensalze hiervon und ihre Verwendung
EP0013983B1 (de) Antineoplastische Mittel auf Basis von nicht oder nur geringfügig irritierenden und/oder promovierenden Diterpenalkoholen und Derivaten davon und deren Herstellung
DE3024855C2 (enExample)
DE2549783C3 (de) Triglyceride mit entzündungshemmender Wirkung
DE3129750A1 (de) 5'-aminoalkyl-4',4,8-trialkylpsoralene
DE2003430C3 (de) p-Benzoylphenoxyisobuttersäureester, ihre Herstellung und diese enthaltende Arzneimittel
EP0217372B1 (de) Neue polyoxygenierte Labdan-Derivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Medikamente
DE3033897C2 (enExample)
DE3033896C2 (enExample)
DE3033895C2 (enExample)
EP1763520B1 (de) Verwendung von trisubstituierten benzopyranonen
DD201903A5 (de) Verfahren zur herstellung von derivaten des thienopyridonons
DE3129749A1 (de) 8-aminoalkyl-4-alkylisopsoralene
DE3337207A1 (de) Verfahren zur herstellung von psoralenfreien alkylangelicinen
DE2632118B2 (de) Apovincaminolester und Verfahren zu deren Herstellung und Arzneimittel
DE2850509A1 (de) Antidermatophytisches mittel und verwendung desselben zur bekaempfung von dermatomycosen
DE2007345A1 (de) Neue substituierte Hexahydroimidazochinoline und deren Säureanlagerungssalze
EP0351720B1 (de) Verwendung substituierter 3,4-Dihydro-2H-benzopyrane als Heilmittel gegen obstruktive Funktionsstörungen der Lunge
DE29923419U1 (de) Neue Xanthonverbindungen und diese enthaltende Arzneimittel
DE69609314T2 (de) Amorph piretanide, polymorphe davon, verfahren zur dessen herstellung und ihre verwendung
DE2253914C3 (de) Chromon-3-acrylsaeuren, verfahren zu ihrer herstellung sowie diese verbindung enthaltende arzneimittel
DE3204630C2 (enExample)
EP0345598B1 (de) Zytostatisch wirksame Anthracyclinderivate
CH634076A5 (de) Verfahren zur herstellung von vincaalkaloiden.

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Free format text: RECHTS- UND PATENTANWAELTE REBLE & KLOSE, 68165 MANNHEIM

8339 Ceased/non-payment of the annual fee